The TATA-binding protein (TBP)-associated factor TAF II 250 is the largest component of the basal transcription factor IID (TFIID). A missense mutation that maps to the acetyltransferase domain of TAF II 250 induces the temperature-sensitive (ts) mutant hamster cell lines ts13 and tsBN462 to arrest in late G 1 . At the nonpermissive temperature (39.5°C), transcription from only a subset of protein encoding genes, including the G 1 cyclins, is dramatically reduced in the mutant cells. Here we demonstrate that the ability of the ts13 allele of TAF II 250 to acetylate histones in vitro is temperature sensitive suggesting that this enzymatic activity is compromised at 39.5°C in the mutant cells. Mutagenesis of a putative acetyl coenzyme A binding site produced a TAF II 250 protein that displayed significantly reduced histone acetyltransferase activity but retained TBP and TAF II 150 binding. Expression of this mutant in ts13 cells was unable to complement the cell cycle arrest or transcriptional defect observed at 39.5°C. These data suggest that TAF II 250 acetyltransferase activity is required for cell cycle progression and regulates the expression of essential proliferative control genes.
Precise regulation of gene transcription is intimately involved in many biological functions such as cell proliferation, differentiation, and development. Biochemical studies have demonstrated that one of the key players in the regulation of RNA polymerase II-dependent gene expression is the transcription factor IID (TFIID). TFIID is a multisubunit complex consisting of the TATA binding protein (TBP) and TBP-associated factors (TAF II s) (7, 37) . It is the only general factor that possesses sequence-specific DNA binding activity (15, 26) , and the binding of TFIID to the promoter region nucleates the assembly of a functional transcription initiation complex (4, 38) . The TAF II subunits of TFIID have been shown to interact with promoter-selective transcriptional regulators and play an essential role in transducing the activation signal from enhancer binding proteins to the basal machinery (40) . Studies also have demonstrated that some TAF II s are involved in directing core promoter function (39) . Therefore, the TAFs play a crucial role in transcriptional regulation.
A functional link between gene transcription and cell cycle progression has been provided with the cloning of TAF II 250 and the discovery that the gene encoding this largest subunit of TFIID is identical to CCG1 (cell cycle gene 1), a gene able to complement the late G 1 arrest of the temperature-sensitive (ts) mutant hamster cell lines ts13 and tsBN462 (14, 28, 30, 32) . Further characterization of ts13 and tsBN462 cells has revealed that both cell lines contain a single base pair change resulting in a glycine-to-aspartic acid amino acid substitution in the TAF II 250/CCG1 protein (11) . Furthermore, studies with the two systems have yielded comparable results and revealed that despite having a mutation in the general machinery, both cell lines do not exhibit a global defect in mRNA synthesis (21, 31, 36, 42) . Instead, transcriptional regulation at only a subset of promoters appears to be altered at the nonpermissive temperature (39.5°C). Expression of the cell cycle regulators cyclin A, D1, and E is reduced dramatically at 39.5°C, while the levels of p21 and p27, cyclin-dependent kinase inhibitors, are upregulated (29, 31, 36, 42) . By contrast, the expression of other growth-related genes such as c-fos and c-myc remains unaffected in the mutant cells. These findings strongly suggest that a TAF II 250-dependent transcriptional defect is responsible for the ts13 mutant phenotype.
In Saccharomyces cerevisiae, mutant strains harboring conditional alleles of TAF II 145, the yeast homologue of TAF II 250, also arrest in late G 1 under restrictive conditions (41) . A genome-wide analysis of gene expression dependence on TAF II 145 has been performed using high-density oligonucleotide arrays technology (16) . Of the 5,441 genes that were scored, 16% displayed a dependence on TAF II 145 similar to that observed for RNA polymerase II, suggesting that this subset of genes display a direct transcriptional requirement for TAF II 145. Interestingly, many of the TAF II 145-dependent genes are involved in either cell cycle progression, DNA repair, or DNA synthesis. Thus, these results further support our hypothesis that the cell cycle arrest observed in ts13 cells is due to the misregulated expression of cellular growth factors fundamental for progression through the G 1 and S phases of the cell cycle.
A strong correlation has been shown between the level of histone acetylation and the transcriptional activity of a chromosomal domain. Hyperacetylated histones have been found to predominate in regions of the genome that are actively transcribing genes (12) , while hypoacetylated histones prevail within transcriptionally silenced domains (2) . The current model is that acetylation of lysine residues in the basic amino terminal tails of the core histones destabilizes the higher-ordered structure of the nucleosomes rendering the DNA more accessible to the transcriptional machinery (8, 19) . This intimate relationship between histone acetylation and transcriptional control was further strengthened by the discovery that the yeast transcriptional regulator GCN5 and the related human protein, hGCN5, both possess histone acetyltransferase (HAT) activity (3). GCN5 functions as an adapter protein and facilitates the action of acidic activators in yeast (9, 23) . Mu-tations in GCN5 do not have a global effect on gene transcription, similar to that observed for the ts13 allele of TAF II 250. Thus, GCN5 also appears to be selective in the genes that it regulates.
The human TAF II 250 subunit of TFIID and its homologues in Drosophila and yeast have been reported to be HATs (24) . Deletion analysis of the Drosophila and yeast proteins and sequence homology indicate that the HAT domain of human TAF II 250 maps between amino acids 517 and 976. The ts13 mutation, which corresponds to amino acid 716 in the human protein, resides in the HAT domain of TAF II 250. This finding, taken together with the studies on GNC5, has led us to hypothesize that the ts13 mutation compromises the HAT activity of TAF II 250, resulting in the gene-selective defect in mRNA synthesis and ultimately cell cycle arrest. Consistent with this model, we report here that the HAT activity of the mutant form of TAF II 250 present in ts13 cells displays temperature sensitivity in vitro. In addition, we demonstrate that TAF II 250 HAT activity is necessary for cell proliferation and efficient transcription from the cyclin A and D1 promoters. Therefore, the HAT activity of TAF II 250, the largest subunit of TFIID, appears to play a crucial role in the expression of key cell cycle control genes and the regulation of cell proliferation.
MATERIALS AND METHODS
Cell lines and cell culture. ts13 cells were cultured in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (HyClone), L-glutamine, and penicillin-streptomycin and grown at 33.5°C in a humidified incubator containing 10% CO 2 . Sf9 cells were propagated in supplemented Hink's TNM-FH insect medium (JHR Biosciences) and grown in spinner culture at 27°C in the absence of CO 2 .
Luciferase reporter constructs. Cyclin A-and c-fos-luciferase promoter constructs have been previously described (43) . The cyclin D1 reporter plasmid was constructed by cloning the EcoRI-to-PvuII fragment of pD1-GO651 (kindly provided by Yue Xiong) into the SmaI site of pGL2-basic (Promega).
Expression and purification of recombinant proteins. Histidine-tagged human TBP (His-hTBP) was expressed in bacteria as follows. Bacteria containing the TBP expression plasmid were grown at 37°C to an optical density at 600 nm of 0.5. Cells were diluted 10-fold and again grown at 37°C to an optical density at 600 nm of 0.5. Expression of His-hTBP was induced with the addition of 0.4 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). After 1 to 3 h of induction at 30°C, cells were harvested by centrifugation and resuspended in HIG buffer (25 mM HEPES-KOH [pH 7.6], 5 mM imidazole, 10% glycerol) containing 0.1% NP-40 and 400 mM KCl. After the addition of lysozyme (0.5 mg/ml) and 30 min of incubation at 4°C, the cells were lysed by sonication.
Human wild-type (WT) TAF II 250, ts TAF II 250, and HAT mutant (HATmt) TAF II 250 were expressed as hemagglutinin (HA)-tagged proteins in Sf9 cells, using the baculovirus expression system. TAF II 150 was expressed as a FLAGtagged fusion protein in Sf9 cells. For protein production, ϳ7.5 ϫ 10 5 Sf9 cells were seeded per 10-cm dish and infected at a multiplicity of infection of 1 to 2. Approximately 48 h postinfection, the cells were lysed in 0.4 M HEMG buffer (25 mM HEPES [pH 7.6], 400 mM KCl, 12.5 mM MgCl 2 , 0.1 mM EDTA, 10% glycerol, 0.5% NP-40) by sonication. Affinity purification was performed as follows. A 100-l aliquot of cell extract was incubated with 1 to 2 l of anti-HA ascites fluid for 1.5 h at 4°C, followed by addition of 25 l of 50% slurry of protein A-Sepharose (PAS). After an additional 1 h at 4°C, the Sepharose beads were washed three times with 1 ml of wash buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM EDTA, 10% glycerol, 0.5% [vol/vol] NP-40, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, leupeptin [1 g/ml], pepstatin [1 g/ ml]). The immobilized proteins were used immediately for HAT assays.
In vitro HAT assays. HAT assays were performed essentially as described previously (24) . Affinity-purified WT, ts mutant and HATmt TAF II 250 proteins were washed once with 1 ml of assay buffer (50 mM Tris-HCl [pH 8.0], 10% glycerol, 0.1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride), and the immune complexes were resuspended in 300 l of assay buffer; 30-l aliquots of the immune complex mixture were preincubated at either 25 or 37°C for 1 h, followed by an additional 30-min incubation in the presence of 25 g of core histones (Sigma type II-AS from calf thymus) and 0.25 Ci of [ 3 H]acetyl coenzyme A (Amersham). The entire reaction was filtered through P81 paper and washed with 50 mM sodium carbonate (pH 9.2). Histone acetylation was measured by liquid scintillation. The amount of TAF II 250 added to the reactions was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with a bovine serum albumin standard and Coomassie blue staining.
TAF II 250 protein interaction assays. Immunopurified WT and HATmt TAF II 250 proteins immobilized on anti-HA antibody bound to PAS beads were incubated with either crude Sf9 TAF II 150-or bacterial TBP-containing cell extracts. After 2 h of incubation at 4°C, the retained proteins were washed extensively, dissociated from the beads, and separated by SDS-PAGE. Silver staining and Western blot analysis using anti-FLAG and anti-TBP antibodies were performed to visualize bound proteins.
Complementation of cell cycle arrest. ts13 cells were seeded at ϳ7.5 ϫ 10 5 cells/10-cm-diameter dish and grown overnight at 33.5°C. Cells were transfected via calcium phosphate precipitation with 0.5 g of CS2ϩMT, CS2ϩMT WT TAF II 250, or CS2ϩMT HATmt TAF II 250 expression vector. After 6 h at 33.5°C, the cells were washed with phosphate-buffered saline, fresh medium was added, and half of the plates were shifted to 39.5°C. The number of viable colonies at 39.5°C was determined after a 2-week period. Transient transfection assays. ts13 cells were maintained at 33.5°C or shifted to 39.5°C for 2 h before the introduction of DNA. Cells were transiently transfected as described above with 0.5 g of the indicated CS2ϩMT construct, 0.5 g of ␤-galactosidase expression vector, and 1 g of luciferase reporter construct containing either the c-fos, cyclin A, or cyclin D1 promoter. The cells were washed after 6 h in the presence of DNA and harvested 24 h posttransfection in reporter lysis buffer (Promega). Luciferase activity was determined using standard protocols and normalized for transfection efficiency by ␤-galactosidase activity (13) .
RESULTS
HAT activity of ts13 TAF II 250 mutant protein is ts in vitro. TAF II 250, the largest subunit of TFIID, is a multifunctional protein that directly interacts with components of TFIID (44), as well as the cellular proteins Rb (33) and MDM2 (20) . In addition, the TAF II 250 protein possesses HAT (24) and kinase (6) activities. The functional role of these different properties of TAF II 250 is not clearly understood.
The ts mutant hamster cell line ts13 harbors a single missense mutation (glycine to aspartic acid) in the TAF II 250 subunit of TFIID which induces the cells to arrest in the late G 1 phase of the cell cycle at 39.5°C (11) . The mutation responsible for the ts13 mutant phenotype maps to the HAT domain of the protein (Fig. 1A) . To determine if this mutation disrupts TAF II 250 HAT activity, we examined the ability of the WT and ts TAF II 250 proteins to acetylate histones in vitro. Sf9 insect cells were infected with recombinant baculoviruses expressing an HA-tagged version of WT or ts TAF II 250. The HA-tagged proteins were immunoaffinity purified from crude Sf9 cell lysates, using an anti-HA ascites fluid. The purified proteins, as shown in Fig. 1B , subsequently were added to reaction mixtures that contained the core histones and [ 3 H]acetyl coenzyme A. It has been reported that activation of transcription in ts13 nuclear extracts is detected when the reactions are carried out at 25°C. However, the ability of the mutant cell extracts to support transcriptional activation is abolished at 37°C, suggesting that the ts TAF II 250 present in the ts13 nuclear extract is functionally defective at the higher temperature. In addition, ts13 cells grow at a much lower rate and appear sickly at 37°C. For these reasons, we have elected to use 25 and 37°C as our permissive and nonpermissive temperatures, respectively, in vitro. When the reactions were incubated at 25°C, WT and ts TAF II 250 displayed comparable levels of HAT activity (Fig.  1C) . By contrast, when the reaction temperature was increased to 37°C, the ability of the ts mutant protein to acetylate histones was lower than that of its WT counterpart (Fig. 1C) . Therefore, the HAT activity of TAF II 250 is ts in vitro, suggesting that this function of TAF II 250 is compromised in vivo in ts13 cells at 39.5°C.
HAT-deficient TAF II 250 protein is unable to complement the ts13 cell proliferative defect. The reduction in TAF II 250 HAT activity under conditions that cause growth arrest of ts13 cells suggests that this enzymatic activity is required for cell cycle progression, specifically through G 1 into S phase. We propose that at 39.5°C, and not at the permissive temperature (Fig. 2A) . Studies on hSSAT have demonstrated that site-directed mutagenesis of the two glycine residues abolished acetyl coenzyme A binding and acetyltransferase activity (22) . Based on these findings, we mutated the conserved glycine residues present in human TAF II 250 (Fig. 2B) . As expected, the HAT activity of the resulting mutant protein was less than that of WT TAF II 250 (Fig. 2C) . Furthermore, this reduction in HAT activity was observed at both 25 and 37°C in vitro.
There exists the possibility that mutagenesis of the two glycine residues described above could alter additional functions of TAF II 250. This outcome would hinder our ability to draw any conclusions about the function of TAF II 250 HAT activity from studies with the mutant protein. Thus, we examined the ability of the TAF II 250 HAT mutant to interact with TBP and TAF II 150, two subunits of TFIID that directly contact TAF II 250. In coimmunoprecipitation experiments, we observed that the HAT mutant immobilized on anti-HA PAS beads bound to TBP (Fig. 3A, lanes 2 and 5) and TAF II 150 (Fig. 3B , lanes 2 and 5) as effectively as WT TAF II 250.
The successful generation of a temperature-independent TAF II 250 HAT mutant (HATmt) enabled us to more directly test the requirement for TAF II 250 HAT activity in cell proliferation. ts13 cells were transfected with a control, WT TAF II 250, or HATmt TAF II 250 expression vector and maintained at 33.5 or 39.5°C. While expression of WT TAF II 250 resulted in cell proliferation (265 colonies/g of DNA) at the nonpermissive temperature, no viable colonies were detected with the HATmt or control vector. The lack of complementation cannot be attributed to differences in protein expression, as comparable levels of the WT and HATmt TAF II 250 proteins were detected in the transfected cell lysates by Western blot analysis (data not shown). These findings strongly indicate that the HAT activity of TAF II 250 is necessary for cellular proliferation.
Efficient transcription from the cyclin A and D1 promoters requires TAF II 250 HAT activity. In addition to the inability to progress through the G 1 phase of the cell cycle, ts13 cells exhibit a dramatic reduction in cyclin A and D1 gene transcription. This transcriptional defect is overcome by the exogenous expression of WT TAF II 250 (29, 31, 36, 42) . However, there is some question as to whether the decrease in cyclin A transcription is a direct consequence of the Gly690Asp mutation in TAF II 250. On the other hand, there is general agreement that the cyclin D1 promoter is a direct target of TAF II 250. Therefore, we tested whether expression of HATmt TAF II 250 could overcome the cyclin A and D1 transcriptional defect observed at the nonpermissive temperature. ts13 cells were cotransfected with the control, WT, or HATmt TAF II 250 expression vector along with luciferase reporter constructs containing ei- ther the ts cyclin A, ts D1, or resistant c-fos promoter. Approximately 24 h posttransfection, the transcriptional activity of each promoter construct was determined. In the presence of the control vector, transcription from the cyclin A and D1 promoters was markedly reduced at 39.5°C due to the presence of ts13 TAF II 250 (Fig. 4) . Expression of WT TAF II 250 in the cells dramatically reduced the temperature sensitivity of the cyclin A and D1 promoters (Fig. 4) . The HATmt TAF II 250 was unable to restore transcriptional activity to cyclin A or cyclin D1 at 39.5°C (Fig. 4) . By contrast, expression of the WT and HATmt proteins had no significant effect on c-fos promoter activity (Fig. 4) . Therefore, the decrease in c-fos transcriptional activity observed at 39.5°C appears not to be TAF II 250 dependent. We confirmed by Western blot analysis that comparable amounts of WT and HATmt TAF II 250 were expressed at each temperature in the transfected ts13 cells (data not shown). Thus, the HAT activity of TAF II 250 is required for transcription at only a subset of promoters. protein kinase, and HAT activities. However, the functions necessary for TAF II 250's role in transcriptional coactivation and cell proliferation remain unclear.
DISCUSSION
Although a complete loss of TAF II 250 expression is lethal (27) , a single missense mutation, found in ts13 and tsBN462 cells, has the effect of altering transcription of select cell cycle regulators and leads to a proliferative block in late G 1 (11, 31, 36, 42) . Therefore, the ts13 cell line represents a good model system in which to identify TAF II 250's role in transcriptional regulation and cell proliferation. Until now, no specific function of TAF II 250 has been implicated in the ts13 mutant phenotype. Here, we present evidence that HAT activity of the ts13 TAF II 250 mutant is ts in vitro. The importance of the hypothesized loss of TAF II 250 HAT activity was examined further by targeting the acetyl coenzyme A binding pocket in TAF II 250. The residues mutated are located within the TAF II 250 HAT domain more than 100 amino acids away from the original Gly-to-Asp mutation and ideally should not affect the same microenvironment of the protein. Characterization of the acetyl coenzyme A binding mutant indicates that in vitro HAT activity is decreased at all temperatures compared to its WT counterpart. In complementation experiments, the TAF II 250 HAT mutant was unable to overcome the ts13 transcriptional or proliferative defect, suggesting that TAF II 250 HAT activity is necessary for the proper transcription of a select set of protein encoding genes essential for progression through the G 1 phase of the cell cycle.
Transcriptional role for TAF II 250 HAT activity. The strong correlation between histone acetylation and transcriptional activity of a chromosomal domain has led to the current model that acetylation increases the accessibility of DNA to transcription factors. Many transcriptional regulatory proteins possess HAT activity, including p300/CREB binding protein (CBP), ACTR, SRC-1, P/CAF, GCN5, and TAF II 250 (3, 5, 24, 25, 34, 45) . The majority of these factors are considered coactivators that interact with a wide variety of nuclear receptors and enhancer binding proteins (35) . Evidence for targeting HAT activity stems from studies on yeast GCN5, where mutagenesis of the HAT domain leads to a promoter-specific decrease in transcription (18) . A number of different models can be proposed to account for this promoter-selective requirement for HAT activity. In the simplest case, HATs are recruited to only a subset of promoters via interactions with specific enhancer and/or upstream element binding proteins. However, this model cannot be applied to TAF II 250, as it is a subunit of TFIID and thus an integral part of the general machinery present at all protein-encoding genes. If TAF II 250 is found on all transcriptionally active genes, the requirement for TAF II 250 acetyltransferase activity may be determined by the promoter context. The specific placement of nucleosomes away from transcription factor binding sites could render a promoter less dependent on histone acetylation. Alternatively, multiple HATs are recruited to some but not all promoters, and the mutation in ts13 cells uncovers promoters which recruit TAF II 250 as the only HAT. Upon inactivation of TAF II 250 HAT activity, transcription from these promoters would be severely compromised.
Transcription factors as potential substrates for TAF II 250 HAT activity. Recently p300/CBP, a well-characterized HAT, has been shown to acetylate the transcription factors p53 and GATA-1, stimulating their DNA binding activities (1, 10) . These results have led to the hypothesis that acetylation of nonhistone proteins may have important regulatory functions. The specific activity of TAF II 250's HAT activity is quite low compared to that of many other HATs. Therefore, it may be more accurate to classify TAF II 250 as an acetyltransferase, as the true substrate for this activity may not be histones. Genetic analysis of the cyclin A promoter has led to the identification of a TAF II 250-dependent upstream regulatory element that contains an activating transcription factor (ATF) binding site (43) . One potential model is that certain forms of ATF or CREB are substrates for TAF II 250 HAT activity. The acetylation of these proteins may enhance the ability of these regulatory proteins to bind DNA and activate gene transcription. In an examination of basal transcription factors, it has been reported that TFIIE␤ (p34 subunit) can be acetylated by the TAF II 250 protein in vitro, but the biological significance of this acetylation is unknown (17) . Future studies may reveal other physiologically relevant substrates more indicative of TAF II 250 function in vivo.
In conclusion, we have demonstrated a role for TAF II 250 acetyltransferase activity in mediating efficient gene transcription. The acetylation event is likely to activate transcription from only a subset of genes, including those required for cell cycle progression. These results may represent a novel mechanism by which strict control of proliferative protein expression is maintained. Future studies will focus on the regulation of TAF II 250 acetyltransferase activity and may unveil new and novel regulatory pathways involved in cell cycle control. assays. We especially thank members of the Wang lab for valuable discussions and G. S. McKnight for critical reading of the manuscript. E. L. Dunphy was supported in part by Public Health Service National Research Service Award T32 GM07270 from the National Institute of General Medical Sciences. This work was supported by research project grant RPG-98-201-CCG from the American Cancer Society and by startup funds from the Howard Hughes Medical Institute.
